Western Diet on Cardiometabolic and Immune Function

Description

This study will implement a Western Diet (WD) to understand cardiometabolic and immune function in middle-aged adults (50- 64 years old). Vascular health, intestinal permeability, and T-cell function will be examined before, during, and after the WD. The WD is a 10-day diet and will consist of 25% of total energy from added sugars.

Conditions

Aging, Diet, Healthy

Study Overview

Study Details

Study overview

This study will implement a Western Diet (WD) to understand cardiometabolic and immune function in middle-aged adults (50- 64 years old). Vascular health, intestinal permeability, and T-cell function will be examined before, during, and after the WD. The WD is a 10-day diet and will consist of 25% of total energy from added sugars.

Effects of a 10-day Western Diet on Cardiometabolic and Immune Function in Midlife Adults

Western Diet on Cardiometabolic and Immune Function

Condition
Aging
Intervention / Treatment

-

Contacts and Locations

Newark

University of Delaware, Newark, Delaware, United States, 19713

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * ability to provide informed consent
  • * men and postmenopausal women aged 50-64 years
  • * systolic blood pressure \< 130 mmHg; diastolic blood pressure \< 90 mmHg
  • * body mass index (BMI) \<30 kg/m2 and % body fat \< 25% for men and \< 33% for women
  • * fasting triglycerides \< 200 mg/dl (\< 2.3 mmol/L)
  • * low density lipoprotein (LDL) cholesterol \<160 mg/dl (4.14 mmol/L)
  • * fasting plasma glucose \<126 mg/dl (\<7.0 mmol/L)
  • * weight stable in the prior 6 months (≤ 2 kg weight change)
  • * blood chemistries indicative of normal liver enzymes and renal function (estimated glomerular filtration rate using the Modification of Diet in Renal Disease (MDRD) prediction equation must be \>60 ml/min/1.73 m\^2)
  • * current use of medications or supplements known to lower blood triglycerides or cholesterol (e.g., fibrates, statins, high dose niacin, high dose omega-3 supplement)
  • * chronic clinical diseases (e.g., coronary artery/peripheral artery/cerebrovascular diseases, heart failure, diabetes, chronic kidney disease requiring dialysis, neurological or autoimmune conditions affecting cognition (e.g. Alzheimer's disease or other forms of dementia, Parkinson's disease, epilepsy, multiple sclerosis, large vessel infarct)
  • * major psychiatric disorder (e.g. schizophrenia, bipolar disorder)
  • * current or past (i.e., last 3 months) use of anti-hypertensive or other cardiovascular-acting medications known to influence vascular function and/or arterial stiffness
  • * current medication use likely to affect central nervous system (CNS) functions (e.g. long active benzodiazepines)
  • * concussion within last 2 years and ≥ 3 lifetime concussions
  • * heavy alcohol consumption (≥8 drinks/week for women and ≥15 drinks/week for men)
  • * recent major change in health status within the previous 6 months (i.e., surgery, significant infection, or illness)
  • * current smoking within the past 3 months.

Ages Eligible for Study

50 Years to 64 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of Delaware,

Christopher Martens, Ph.D., PRINCIPAL_INVESTIGATOR, University of Delaware

Study Record Dates

2027-07